Monday July 22, 2024



Ghana Approves First Ever Malaria Vaccine

April 16, 2023

The first malaria vaccine has been approved for use in Ghana. Malaria is a disease that kills 620,000 people annually, most of whom are children.

The R21 Vaccine, developed by scientists at the University of Oxford, is expected to revolutionise the centuries-long fight against malaria. 

For over a century, scientists have been attempting to develop a vaccine. 

The vaccine is already being considered for global approval by the World Health Organization. 

The R21 Vaccine has been shown in trials to be 80% effective in protecting against malaria, in trials. It is given in three doses, with a later one-year booster. 

The Serum Institute of India plans to begin production of 100-200 million doses per year and will most likely establish a factory in Ghana. 

Malaria is primarily transmitted by a specific type of mosquito and primarily affects tropical countries in Africa, Asia, South America, and Central America.

Europe Faces Growing Water Crisis

Europe Faces Growing Water Crisis

According to a study released in January by Graz University of Technology in Austria, Europe has been experiencing drought since 2018 and its water situation is currently "very precarious."

July 22, 2024